How it works:
Suppresses immune system activity
Reduces antibody and inflammatory cell production
Prevents graft rejection
Improves outcomes in chronic autoimmune conditions
Recommended for:
Patients after organ transplantation
Systemic autoimmune diseases
Inflammatory bowel diseases (Crohn’s disease, ulcerative colitis)
Severe cases of rheumatoid arthritis under medical supervision
Prevention of transplant rejection
Rheumatoid arthritis
Systemic lupus erythematosus
Crohn’s disease
Ulcerative colitis
Glomerulonephritis and other autoimmune conditions
AZORAN is taken orally after meals. Dosage is individualised based on clinical condition, body weight, age, and liver function. Long-term use requires regular blood and liver monitoring
Contraindications:
Hypersensitivity to azathioprine
Severe infections
Pregnancy and breastfeeding (unless prescribed)
Severe liver or bone marrow impairment
Side Effects:
Bone marrow suppression (leukopenia, anaemia)
Increased susceptibility to infections
Nausea, vomiting
Liver toxicity
Skin rashes or reactions
Increased long-term cancer risk
